- Supported exchanges /
- F /
- 74D.F
HLS THERAPEUTICS INC. (74D F) stock market data APIs
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.
HLS THERAPEUTICS INC. Financial Data Overview
2.54 | |
2.54 | |
- | |
2.54 | |
2.54 | |
1.95-3.46 | |
86 266 K | |
31 793 K | |
58 892 K | |
1.065 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
HLS THERAPEUTICS INC. Fundamental Data is available in our Financial Data APIs
- Net Revenue 58 892 K
- EBITDA 17 304 K
- Earnings Per Share -0.69
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get HLS THERAPEUTICS INC. Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get HLS THERAPEUTICS INC. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: